A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus

• Published in: Journal of molecular biology Vol. 429; no. 17; pp. 2694 - 2709
• Main Authors: Wu, Nicholas C., Wilson, Ian A.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 18.08.2017
• Subjects: Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; antibody; epitopes; evolution; Evolution, Molecular; glycoproteins; glycosylation; hemagglutinin; Hemagglutinin Glycoproteins, Influenza Virus - chemistry; Hemagglutinin Glycoproteins, Influenza Virus - genetics; Hemagglutinin Glycoproteins, Influenza Virus - immunology; hemagglutinins; humoral immunity; Immune Evasion; influenza; influenza A virus; influenza vaccines; innate immunity; membrane fusion; Mutant Proteins - chemistry; Mutant Proteins - genetics; Mutant Proteins - immunology; Mutation; neutralizing antibodies; Orthomyxoviridae; Orthomyxoviridae - immunology; protein structure; therapeutics; virology; viruses; CDR; protein structure; RBS; NA; antibody; Fab; hemagglutinin; HA; evolution; bnAbs; influenza A virus
• ISSN: 0022-2836; 1089-8638; 1089-8638
• DOI: 10.1016/j.jmb.2017.06.015

Influenza virus evolves rapidly to constantly escape from natural immunity. Most humoral immune responses to influenza virus target the hemagglutinin (HA) glycoprotein, which is the major antigen on the surface of the virus. The HA is composed of a globular head domain for receptor binding and a stem domain for membrane fusion. The major antigenic sites of HA are located in the globular head subdomain, which is highly tolerant of amino acid substitutions and continual addition of glycosylation sites. Nonetheless, the evolution of the receptor-binding site and the stem region on HA is severely constrained by their functional roles in engaging the host receptor and in mediating membrane fusion, respectively. Here, we review how broadly neutralizing antibodies (bnAbs) exploit these evolutionary constraints to protect against diverse influenza strains. We also discuss the emerging role of other epitopes that are conserved only in subsets of viruses. This rapidly increasing knowledge of the evolutionary biology, immunology, structural biology, and virology of influenza virus is invaluable for development and design of more universal influenza vaccines and novel therapeutics. [Display omitted] •Antigenic variation is a major challenge for influenza vaccine design.•Comprehending evolutionary constraints for influenza function is critical for vaccine development.•Broadly neutralizing antibodies reveal conserved epitopes.•Eliciting long-term heterosubtypic immunity is the ultimate goal for vaccine design.